DMAC R&D Expenses
Diamedica Therapeutics Inc · R&D Expenses
DMAC R&D Expenses
Latest reported$29.28Mperiod ending
DMAC R&D Expenses ($462.00K → $29.28M)
Annual R&D Expenses
High-resolution chart · PNG
DMAC r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 24,614,000 | |
| 19,057,000 | |
| 13,110,000 | |
| 7,839,000 | |
| 8,765,000 | |
| 8,205,000 | |
| 7,900,000 | |
| 4,522,000 | |
| 3,206,000 | |
| 1,763,415 | |
| 886,073 | |
| 3,712,532 | |
| 3,780,897 | |
| 5,207,811 | |
| 2,326,612 | |
| 803,984 | |
| 1,365,556 | |
| 1,039,930 | |
| 1,067,177 | |
| 617,257 | |
| 22,751 | |
| 461,996 |